Target intelligence / Profile preview

Renal tubule

Molecular classification
Other (Anatomical structure), Contains multiple classes: Transporters (e.g., SGLT2), Enzymes (e.g., carbonic anhydrase), Ion channels
01

Overview

The renal tubule is a long and convoluted anatomical structure forming part of each nephron—the basic functional unit in the kidney. It consists primarily of three main segments—proximal convoluted tubule, loop of Henle, and distal convoluted tubule—which sequentially process glomerular filtrate through reabsorption and secretion. The primary functions are to reclaim essential nutrients/electrolytes/water back into circulation while secreting waste products into urine. Each segment contains specialized epithelial cells expressing distinct sets of transporters and enzymes that mediate these processes via active/passive transport mechanisms. Dysfunction or genetic defects affecting proteins expressed in these regions can result in inherited or acquired diseases known as “tubulopathies.” The term “renal tubule” does not refer to any single therapeutic target but encompasses numerous potential drug targets located along its length.

Other names
Tubular part of nephronKidney tubule
02

Mechanism of action

Not applicable for entire renal tubule; mechanisms depend on targeted molecule: Inhibition of sodium-glucose co-transporter (SGLT2); Inhibition/blockade of ion transporters/channels affecting reabsorption/secretion processes in various segments.

03

Biological functions

Reabsorption of water and solutes from filtrateSecretion of substances into urineRegulation of acid-base balanceMaintenance of electrolyte homeostasis
04

Disease associations

Other (Tubulopathies such as renal tubular acidosis)Chronic kidney disease progressionElectrolyte disorders
05

Safety considerations

Electrolyte imbalances (hyponatremia, hypokalemia)Volume depletion/dehydration
06

Interacting drugs

SGLT2 inhibitors (e.g., dapagliflozin)

2 more in the full profile.

07

Biomarkers

Urinary markers indicating tubular injury include N-acetyl-beta-D-glucosaminidaseKidney injury molecule–1 (KIM–1)Neutrophil gelatinase-associated lipocalin (NGAL)

Beyond the preview

Go deeper on Renal tubule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal tubule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call